TSX News -
ProMIS Neurosciences Issues Year-to-Date Update, Highlighting 2018 Accomplishments
Development of therapeutic antibodies for Alzheimer’s disease, Parkinson’s disease and ALS are top priorities for drug development and potential partnering […]